Searching around i found this one aswell.
FDA approval mid 2019. Injectable pain relieve.
May not have the benefits of iPPS but still competition.
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.durolane.com/en/what-is-durolane/&ved=2ahUKEwjYk83WwNXuAhWxzjgGHTwiDX4QFjAAegQIAxAC&usg=AOvVaw1GTTBmeC9HuARq3CPpYhuL
research reports and media, page-1182
-
- There are more pages in this discussion • 3,247 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.5¢ | 23.0¢ | $74.06K | 320.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 102830 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 703 | 1 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |